Tech Company Financing Transactions
Cardiac Dimensions Funding Round
Cardiac Dimensions closed a $35 million Series D funding round on 1/6/2023. Investors included Horizon 3, Arboretum Ventures and EQT Life Sciences.
Transaction Overview
Company Name
Announced On
1/6/2023
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series D
Proceeds Purpose
The company intends to use the funds to enroll the U.S. EMPOWER pivotal study of the Carillon therapy, which commenced late last summer and includes leading centers such as the Cleveland Clinic, Columbia University Medical Center, and Ronald Reagan UCLA Medical Center, and expand sales of the Carillon device in several European countries where it has full reimbursement.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5540 Lake Washington Blvd. Northeast
Kirkland, WA 98033
USA
Kirkland, WA 98033
USA
Phone
Website
Email Address
Overview
The CARILLON Mitral Contour System is a groundbreaking, non-surgical device developed to treat functional mitral regurgitation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Wypych
Chief Medical Officer
Steven Goldberg
Vice President
Gretchen Gary
VP - Operations
Bob Calcote
VP - Regulatory Affairs
Matthew Stark
VP - Sales
Carmelo Mastrandrea
Browse more venture capital transactions:
Prev: 1/6/2023: KeyCare venture capital transaction
Next: 1/6/2023: BioVersys venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs